One of the biggest challenges facing biologic drug developers are varying efficacy and the dangers of side effects.

As founder of HUYA Bioscience International, Lady Mireille Gillings built a pioneering model to accelerate the global development of novel biopharmaceutical therapies originating in China.

The administration of US President Donald Trump has taken a series of actions since January, 2025 that directly threaten the foundations of health care, for global and US citizens alike. What started ...

PM: Great scientists, such as Pasteur (of course), Einstein ... and he has been a lecturer in pharmaceutical and biotechnology industry seminars and in business schools for several years.

Under PASTEUR, the federal government would enter ... John Conrad is president & CEO of the Illinois Biotechnology Innovation Organization (iBIO).

Ambassador Brochet outlines shared goals in innovation, trade, and cultural growth as President Macron visits Vietnam.

Press Release - Africa CDC's Platform for Harmonized Health Products Manufacturing (PHAHM), in collaboration with the Team ...

developed in the framework of its broad strategic collaboration focused on the genetics of hearing with the Institut Pasteur. SENS-501 (OTOF-GT) currently being developed in a Phase 1/2 clinical ...